With advancing age, an increasing number of healthy individuals have laboratory signs of
heightened coagulation enzyme activity. Such biochemical hypercoagulability might be the …

With advancing age, an increasing number of healthy individuals have laboratory signs of
heightened coagulation enzyme activity. Such biochemical hypercoagulability might be the …

Gene polymorphisms associated with the plasma levels of fibrinogen, factor VII, and
plasminogen activator inhibitor 1 (PAI-1)—hemostasis proteins that help to predict the risk of …

Abstract On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related
Diseases was held in Palermo, Italy. The lecture of D. Mari on Hemostasis and ageing is …

Objective: Several hemostatic variables are identified as cardiovascular risk markers. In
young and middle‐aged individuals, plasma concentrations of these variables are partly …

The incidence of venous thromboembolism (VTE) is well recognized to increase with aging.
Concurrently, the plasma concentrations of many coagulation factors (eg, fibrinogen, factor …

Advanced age is associated with a dramatic increase in the rates of venous and arterial
thrombotic events. Increases in fibrinogen, factors VIII and IX, and other coagulation …

Do extremely old persons have a genetically favourable profile which has protected them
from cardiovascular death? We have tried to answer this question by measuring DNA …

To investigate causes of the age-dependent increase of thromboembolic events, plasma
coagulation parameters were determined in healthy elderly blood donors in comparison with …

A greater life expectancy has led to an increasing proportion of elderly patients. Increasing
age is an important risk factor for cardiovascular disease, but the mechanism of risk is not …